These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Influence of genetic factors in the modulation of postprandial lipemia. Perez-Martinez P; Lopez-Miranda J; Perez-Jimenez F; Ordovas JM Atheroscler Suppl; 2008 Sep; 9(2):49-55. PubMed ID: 18603482 [TBL] [Abstract][Full Text] [Related]
5. [Role of modified lipoprotein in the development of atherogenic dyslipidaemia]. Zvenigorodskaia LA; Churikova AA Eksp Klin Gastroenterol; 2011; (11):73-8. PubMed ID: 22629724 [TBL] [Abstract][Full Text] [Related]
6. Integrated proteomics and metabolomics analysis reveals differential lipid metabolism in human umbilical vein endothelial cells under high and low shear stress. Venturini G; Malagrino PA; Padilha K; Tanaka LY; Laurindo FR; Dariolli R; Carvalho VM; Cardozo KHM; Krieger JE; Pereira ADC Am J Physiol Cell Physiol; 2019 Aug; 317(2):C326-C338. PubMed ID: 31067084 [TBL] [Abstract][Full Text] [Related]
7. Endocytosis of lipoproteins. Zanoni P; Velagapudi S; Yalcinkaya M; Rohrer L; von Eckardstein A Atherosclerosis; 2018 Aug; 275():273-295. PubMed ID: 29980055 [TBL] [Abstract][Full Text] [Related]
8. The metabolic and pharmacologic bases for treating atherogenic dyslipidaemia. Chan DC; Barrett PH; Watts GF Best Pract Res Clin Endocrinol Metab; 2014 Jun; 28(3):369-85. PubMed ID: 24840265 [TBL] [Abstract][Full Text] [Related]
9. Lipoprotein sialylation in atherosclerosis: Lessons from mice. Yu L; Peng J; Mineo C Front Endocrinol (Lausanne); 2022; 13():953165. PubMed ID: 36157440 [TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein E in lipoprotein metabolism, health and cardiovascular disease. Marais AD Pathology; 2019 Feb; 51(2):165-176. PubMed ID: 30598326 [TBL] [Abstract][Full Text] [Related]
11. Disorders of lipid metabolism in nephrotic syndrome: mechanisms and consequences. Vaziri ND Kidney Int; 2016 Jul; 90(1):41-52. PubMed ID: 27165836 [TBL] [Abstract][Full Text] [Related]
12. ERV1/ChemR23 Signaling Protects Against Atherosclerosis by Modifying Oxidized Low-Density Lipoprotein Uptake and Phagocytosis in Macrophages. Laguna-Fernandez A; Checa A; Carracedo M; Artiach G; Petri MH; Baumgartner R; Forteza MJ; Jiang X; Andonova T; Walker ME; Dalli J; Arnardottir H; Gisterå A; Thul S; Wheelock CE; Paulsson-Berne G; Ketelhuth DFJ; Hansson GK; Bäck M Circulation; 2018 Oct; 138(16):1693-1705. PubMed ID: 29739755 [TBL] [Abstract][Full Text] [Related]